EMEA-003352-PIP01-22 - paediatric investigation plan

Efzofitimod

Key facts

• Active Substance:
  Efzofitimod
• Therapeutic area:
  Immunology-Rheumatology-Transplantation
• Decision number:
  P/0108/2023
• PIP number:
  EMEA-003352-PIP01-22
• Pharmaceutical form(s):
  Concentrate for solution for infusion
• Condition(s) / indication(s):
  Treatment of pulmonary sarcoidosis
• Route(s) of administration:
  Intravenous use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  14/04/2023

Decision

P/0108/2023 : EMA decision of 14 April 2023 on the granting of a product specific waiver for efzofitimod (EMEA-003352-PIP01-22)

Reference Number: EMA/143584/2023